tiprankstipranks
Trending News
More News >

Aurinia Pharmaceuticals Boosts Lupus Nephritis Awareness

Aurinia Pharmaceuticals (AUPH) has released an update.

Confident Investing Starts Here:

Aurinia Pharmaceuticals is intensifying its efforts to combat lupus nephritis (LN) during Lupus Awareness Month with a focus on education and advocacy. The company has launched a campaign to educate rheumatologists on the importance of early LN detection and kidney health, as well as supporting a Lupus Call to Action event featuring Grammy-winner Toni Braxton to promote health equity. These initiatives are part of Aurinia’s broader mission to improve outcomes and access for those affected by LN.

For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App